Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

NCT02522611 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

NIH

Sponsor class

Conditions

Intractable Pain
Palliative Care

Interventions

DRUG: Resiniferatoxin

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)